VRTX

VERTEX PHARMACEUTICALS INC / MA

VRTX · CIK 875320 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$12.0B
20182025
Net Income$4.0B
20182025
Operating CF$3.6B
20182025
Free Cash Flow$3.2B
20182025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$12.0B$11.0B$9.9B$8.9B$7.6B$1.6B$1.4B$0.9B
Cost of Revenue$1.7B$1.5B$1.3B$1.1B$0.9B$0.2B$0.2B$0.1B
Gross Profit
R&D Expense$3.1B$0.5B$0.5B$0.4B
SG&A Expense$1.8B$1.5B$1.1B$0.9B$0.8B$0.2B$0.2B$0.2B
Operating Income$4.2B$-0.2B$3.8B$4.3B$2.8B$0.7B$0.6B$0.1B
Net Income$4.0B$-0.5B$3.6B$3.3B$2.3B$0.6B$0.6B$1.6B
EPS (Basic)$15.46$-2.08$14.05$12.97$9.09$2.32$2.26$6.08
EPS (Diluted)$15.32$-2.08$13.89$12.82$9.01$2.30$2.23$5.97

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Total Assets$25.6B$22.5B$22.7B$18.2B$13.4B$11.8B$8.3B$6.2B
Current Assets$11.2B$9.6B$14.1B$13.2B$9.6B$8.1B$4.8B$3.8B
Cash & Equivalents$5.1B$4.6B$10.4B$10.5B$6.8B$6.0B$3.1B$2.7B
Total Liabilities$7.0B$6.1B$5.1B$4.2B$3.3B$3.1B$2.2B$1.8B
Current Liabilities$3.9B$3.6B$3.5B$2.7B$2.1B$1.9B$1.3B$1.1B
Stockholders' Equity$18.7B$16.4B$17.6B$13.9B$10.1B$4.4B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Operating Cash Flow$3.6B$-0.5B$3.5B$4.1B$2.6B$3.3B$1.6B$1.3B
Investing Cash Flow$-0.9B$-3.8B$-3.1B$-0.3B$-0.3B$0.1B$-1.2B$-0.2B
Capital Expenditures$0.4B$0.3B$0.2B$0.2B$0.2B$0.3B$0.1B$0.1B
Financing Cash Flow$-2.3B$-1.5B$-0.6B$-0.1B$-1.5B$-0.5B$0.1B$-0.1B